March 6, 2020 – ISSCR has become aware of recent claims that stem cells can be used to treat people infected with COVID-19. While stem cell research shows promise for numerous diseases and conditions, there currently are no approved stem cell-based approaches for the prevention and treatment of COVID-19 infection.

The ISSCR is a vocal and active opponent of the premature marketing and commercialization of stem cell therapies that have not been tested in rigorous clinical trials. The Society has released guidelines to help researchers and regulators navigate the translation of cellular therapies. The ISSCR’s public information website is aimed at helping patients, families, and the science-interested public learn about stem cells, better understand the current state of research, and make informed decisions about stem cell treatments.

About the International Society for Stem Cell Research (isscr.org)
Founded in 2002, the International Society for Stem Cell Research (ISSCR) is a global, nonprofit organization that promotes excellence in stem cell science and applications to human health. A community of more than 4,000 stem cell scientists, clinicians, business leaders, ethicists, and educators from 67 countries worldwide, ISSCR members are dedicated to upholding the society’s guidelines for responsible and ethical practice.

Link to article

Pin It on Pinterest

Share This